Saturday 17 October 2026 Export ALLO’s income statement to Excel — free account

Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $22,000.00, down 76.8% from fiscal 2023. In the quarter to June 2026, revenue grew 20,990.9%, EPS grew 43.5% and free cash flow grew 17.7%, each against the same quarter a year earlier.

1.31 0.03 −2.24%

Follow ALLO

Alert me

Market cap: $463.0M
P/E: 0.0×
Fwd P/E: −2.2×
Dividend yield: —
F-score: 3/9
Altman Z: −3.73
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Cash and Short Term Investments Full definition →	332.60	266.89	250.21	252.19	+8 more quarters Free account
Total current assets Full definition →	340.00	273.29	257.75	260.72
Property, Plant, Equpment (Net) Full definition →	67.38	70.02	72.84	75.90
Long-Term Investments Full definition →	90.99	—	8.04	24.94
Long-term assets (Other) Full definition →	13.98	13.82	37.39	37.28
Total non-current assets Full definition →	210.09	122.67	158.16	179.05
Total Assets Full definition →	550.09	395.96	415.91	439.77
Accounts Payable Full definition →	5.96	4.93	4.27	3.70
Accrued Expenses Full definition →	25.76	23.40	28.24	28.13
Total current liabilities Full definition →	31.73	28.33	32.51	31.83
Non-current Liabilities (Other) Full definition →	11.84	16.12	15.80	15.48
Total non-current liabilities Full definition →	82.19	88.75	90.85	92.61
Total liabilities Full definition →	113.92	117.08	123.36	124.44
Additional Paid In Capital Full definition →	2,532.34	2,332.13	2,302.75	2,286.77
Common Stock (Net) Full definition →	0.35	0.25	0.23	0.22
Retained Earnings Full definition →	(2,095.99)	(2,053.32)	(2,010.71)	(1,971.90)
Common Equity (Total) Full definition →	436.18	278.88	292.54	315.33
Shareholders Equity (Total) Full definition →	436.18	278.88	292.54	315.33
Shareholders Equity and Liabilities (Total) Full definition →	550.09	395.96	415.91	439.77
Shares (Common) Full definition →	345.35	244.82	229.41	223.16
Shareholders Equity (Tangible) Full definition →	436.18	278.88	292.54	315.33
Net Debt Full definition →	(332.60)	(266.89)	(250.21)	(252.19)

Show all line items

In millions of $ except per-share values · columns are period end dates

Stockrow Weekly